Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-17

FDA Approved: CALCIPOTRIENE — Supplemental Application (Glenmark Pharmaceuticals Inc.,USA)

View source ↗

Summary

FDA approved a supplemental application for CALCIPOTRIENE from Glenmark Pharmaceuticals, indicating an approved update to the existing ANDA product (supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcipotriene (calcipotriene)

Snippet

SUPPL AP for CALCIPOTRIENE (CALCIPOTRIENE)